283 related articles for article (PubMed ID: 20570702)
1. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
2. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
[TBL] [Abstract][Full Text] [Related]
5. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
Hossain MA; Wade JD; Bathgate RA
Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
[TBL] [Abstract][Full Text] [Related]
6. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
7. Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signaling.
Büllesbach EE; Schwabe C
Biochemistry; 2012 May; 51(20):4198-205. PubMed ID: 22574850
[TBL] [Abstract][Full Text] [Related]
8. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Halls ML; Bathgate RA; Summers RJ
Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
[TBL] [Abstract][Full Text] [Related]
9. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
10. Chemical synthesis and biological activity of rat INSL3.
Smith KJ; Wade JD; Claasz AA; Otvos L; Temelcos C; Kubota Y; Hutson JM; Tregear GW; Bathgate RA
J Pept Sci; 2001 Sep; 7(9):495-501. PubMed ID: 11587188
[TBL] [Abstract][Full Text] [Related]
11. The "hot wires" of the relaxin-like factor (Insl3).
Schwabe C; Büllesbach EE
Ann N Y Acad Sci; 2009 Apr; 1160():93-8. PubMed ID: 19416166
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation.
Fu P; Shen PJ; Zhao CX; Scott DJ; Samuel CS; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
J Endocrinol; 2006 May; 189(2):397-408. PubMed ID: 16648305
[TBL] [Abstract][Full Text] [Related]
13. A novel ultrasensitive bioluminescent receptor-binding assay of INSL3 through chemical conjugation with nanoluciferase.
Zhang L; Song G; Xu T; Wu QP; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2013 Dec; 95(12):2454-9. PubMed ID: 24056075
[TBL] [Abstract][Full Text] [Related]
14. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
15. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
[TBL] [Abstract][Full Text] [Related]
16. Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3).
Büllesbach EE; Schwabe C
Biochemistry; 2007 Aug; 46(34):9722-7. PubMed ID: 17676766
[TBL] [Abstract][Full Text] [Related]
17. Human gene 2 relaxin chain combination and folding.
Tang JG; Wang ZH; Tregear GW; Wade JD
Biochemistry; 2003 Mar; 42(9):2731-9. PubMed ID: 12614168
[TBL] [Abstract][Full Text] [Related]
18. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
19. Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2.
Svendsen AM; Vrecl M; Ellis TM; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J
Endocrinology; 2008 Mar; 149(3):1113-20. PubMed ID: 18063691
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like factor 3 (INSL3)-receptor (RXFP2) network functions as a germ cell survival/anti-apoptotic factor in boar testes.
Sagata D; Minagawa I; Kohriki H; Pitia AM; Uera N; Katakura Y; Sukigara H; Terada K; Shibata M; Park EY; Hasegawa Y; Sasada H; Kohsaka T
Endocrinology; 2015 Apr; 156(4):1523-39. PubMed ID: 25562614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
